Proffered Papers - Care and Treatment among key populations (Science & Clinical Care Theme)
Tracks
.
| Tuesday, August 14, 2018 |
| 4:00 PM - 5:30 PM |
| Cirty Room 1 (Level 1) |
Speaker
Prof Gregory Dore
Program Head, VHCRP
The Kirby Institute, UNSW
Hepatitis C Virus (HCV) Reinfection And Injecting Risk Behavior Following Elbasvir (EBR)/Grazoprevir (GZR) Treatment In Participants On Opiate Agonist Therapy (OAT): Co-Star Part B
4:00 PM - 4:15 PMBiography
Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Australia, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years.
Dr Phillip Read
Director
Kirketon Road Centre
Daily Dosing of Direct Acting Antivirals (DAAs) from a Public Opioid Substitution Treatment (OST) Program for Marginalised Clients in Kings Cross, Sydney
4:15 PM - 4:30 PMBiography
Dr Phillip Read is the Director of the Kirketon Road Centre in Sydney’s Kings Cross. KRC is a primary health care service involved in the prevention, treatment and care of hepatitis among people who use drugs and homeless and marginalised populations.
A/Prof Gail Matthews
Program Head, Therapeutic and Vaccine Research Program, Department Head of Infectious Disease Physician
The Kirby Institute, UNSW Sydney
Prevalence Of Ns5a Resistance Associated Substitutions And Hcv Daa Treatment Outcomes Among People Living With Hiv In Australia
4:30 PM - 4:45 PMBiography
Tanya Applegate leads the research laboratory team in the Viral Hepatitis and Clinical Research Program at the Kirby Institute, UNSW Sydney. Tanya’s interests include HCV translational research, molecular epidemiology and the development and implementation of HCV molecular diagnostics, to improve health care among marginalised populations and resource limited settings.
A/Prof Gail Matthews
Program Head, Therapeutic and Vaccine Research Program, Department Head of Infectious Disease Physician
The Kirby Institute, UNSW Sydney
Phylogenetic Clustering Patterns Among People Living with HIV and Hepatitis C in Australia
4:45 PM - 5:00 PMBiography
Tanya Applegate leads the research laboratory team in the Viral Hepatitis and Clinical Research Program at the Kirby Institute, UNSW Sydney. Tanya’s interests include HCV translational research, molecular epidemiology and the development and implementation of HCV molecular diagnostics, to improve health care among marginalised populations and resource limited settings.
Dr Marianne Martinello
Lecturer
The Kirby Institute, UNSW
High Efficacy Of 8 Weeks Paritaprevir/Ritonavir/Ombitasvir And Dasabuvir Among People With Recent Genotype 1 HCV Infection
5:00 PM - 5:05 PMBiography
Dr Marianne Martinello is an Infectious Diseases Physician at Blacktown Mt Druitt Hospital and a Lecturer in the Viral Hepatitis Clinical Research Program at the Kirby Institute.
Ms Mary Fenech
Nurse Practitioner
Quihn Ltd
Clinicians Attitudes Towards The Treatment Of Patients With Hepatitis C Who Are Injecting Drug Users (Cathpin)
5:05 PM - 5:10 PMBiography
Mary has been a Nurse Practitioner in Hepatology for the past ten years. She has over twenty years’ experience working in chronic liver disease including many years in a large tertiary liver clinic. Mary is also a former President of and remains an active member of the Australasian Hepatology Association.
Lisa Dowdell
St George Hospital
TEST AND TREAT! – A Community Based Viral Hepatitis Screening and Treatment Service in a Sydney Based Needle and Syringe Program (NSP)
5:10 PM - 5:15 PMBiography
Lisa Dowdell, Masters of Nursing (UTAS), works as a Community Liver Disease Nurse Consultant integrating care between the Liver Clinic at St George and Primary Health Care
Ms Virginia McMahon
NSP Supervisor
KRC South
TEST AND TREAT! – A Community Based Viral Hepatitis Screening and Treatment Service in a Sydney Based Needle and Syringe Program (NSP)
5:10 PM - 5:15 PMBiography
Virginia McMahon has wide experience in project management and health service development and is currently the NSP supervisor at KRC-S.
Dr Joe Doyle
Deputy Program Director, Disease Elimination
Burnet Institute
Utilising A Social Network Nurse –Led Model To Engage People Who Inject Drugs In The Community Into HCV Treatment And Care
5:15 PM - 5:20 PMBiography
Dr Joseph Doyle, Senior Lecturer, Monash University and Alfred Health; Deputy Director, Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia
Chair
Suzanne Sheppard-Law
Senior Research Fellow
UTS & SCHN
Edmund Tse
Head Of Hepatology
Royal Adelaide Hospital - Liver Clinic
